ProPhase Labs (PRPH) Acquisitions (2023)
ProPhase Labs' Acquisitions came in at $2.9 million for FY2023.
Powered by 
Analysis
ProPhase Labs (PRPH) Acquisitions (2023) Analysis & Trends
- Acquisitions carries a three-year compound annual growth rate of 5.1% (FY2020 to FY2023).
- The FY2023 figure represents the lowest annual Acquisitions since FY2020.
- Per Business Quant, earlier years put Acquisitions at $9.07 million in FY2021 (+262.6%) and $2.5 million in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.75 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | -17.15 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 23.00 Mn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 11.21 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 | - |
API Access
ProPhase Labs Acquisitions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=acquisitions&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "acquisitions", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=acquisitions&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();